ZA8944B - K+ channel activator/beta-blocker compositions - Google Patents

K+ channel activator/beta-blocker compositions

Info

Publication number
ZA8944B
ZA8944B ZA8944A ZA8944A ZA8944B ZA 8944 B ZA8944 B ZA 8944B ZA 8944 A ZA8944 A ZA 8944A ZA 8944 A ZA8944 A ZA 8944A ZA 8944 B ZA8944 B ZA 8944B
Authority
ZA
South Africa
Prior art keywords
beta
channel activator
blocker
blocker compositions
compositions
Prior art date
Application number
ZA8944A
Other languages
English (en)
Inventor
John Morris Evans
Morris Evans John
Robin Edwin Buckingham
Edwin Buckingham Robin
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10629550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA8944(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA8944B publication Critical patent/ZA8944B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA8944A 1988-01-06 1989-01-04 K+ channel activator/beta-blocker compositions ZA8944B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800199A GB8800199D0 (en) 1988-01-06 1988-01-06 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
ZA8944B true ZA8944B (en) 1990-09-26

Family

ID=10629550

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA8944A ZA8944B (en) 1988-01-06 1989-01-04 K+ channel activator/beta-blocker compositions

Country Status (15)

Country Link
US (1) US5032591A (ja)
EP (1) EP0323745B1 (ja)
JP (1) JPH01224316A (ja)
KR (1) KR890011591A (ja)
AT (1) ATE83375T1 (ja)
AU (1) AU614008B2 (ja)
CA (1) CA1317228C (ja)
DE (1) DE3876773T2 (ja)
DK (1) DK2689A (ja)
ES (1) ES2042776T3 (ja)
GB (1) GB8800199D0 (ja)
GR (1) GR3006857T3 (ja)
NZ (1) NZ227518A (ja)
PT (1) PT89388B (ja)
ZA (1) ZA8944B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921972T2 (de) * 1988-12-13 1995-11-16 Beecham Group Plc Benzopyran und verwandte Verbindungen.
FR2645021A1 (fr) * 1989-03-30 1990-10-05 Sanofi Sa Utilisation d'un agoniste potassique dans le traitement du glaucome
FR2653662B1 (fr) * 1989-10-31 1994-05-13 Rhone Poulenc Sante Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne.
FR2657872B2 (fr) * 1989-11-06 1992-06-12 Sanofi Sa Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
TW224941B (ja) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
DE4004268A1 (de) * 1990-02-13 1991-08-14 Merck Patent Gmbh Pharmazeutische zubereitung
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof
US5643921A (en) * 1990-09-26 1997-07-01 E.R. Squibb & Sons, Inc. Cardiopulmonary bypass and organ transplant using a potassium channel activator
GB9124754D0 (en) * 1991-11-21 1992-01-15 Smithkline Beecham Plc Pharmaceuticals
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
BRPI0519013A2 (pt) * 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
PT2061465E (pt) * 2006-08-23 2013-07-15 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8030518B2 (en) * 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US20080207073A1 (en) * 2007-02-22 2008-08-28 David Michael Jones Coated multi-purpose fabric
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
EP0091748B1 (en) * 1982-04-08 1986-06-18 Beecham Group Plc Antihypertensive benzopyranols
DE3368629D1 (en) * 1982-04-28 1987-02-05 Beecham Group Plc Novel chromenes and chromans
DE3368057D1 (en) * 1982-05-21 1987-01-15 Beecham Group Plc Pharmaceutically active aminobenzopyrans
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308063D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
EP0126311B1 (en) * 1983-05-18 1989-09-13 Beecham Group Plc Benzopyran derivatives.
GB8313679D0 (en) * 1983-05-18 1983-06-22 Beecham Group Plc Active compounds
DE3486354T2 (de) * 1983-05-18 1995-03-30 Beecham Group Plc Chroman- und Chromenderivate.
DE3475786D1 (de) * 1983-09-01 1989-02-02 Beecham Group Plc Chromanol derivatives
DE3477779D1 (en) * 1983-10-13 1989-05-24 Beecham Group Plc Chroman derivatives
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3682331D1 (de) * 1985-06-08 1991-12-12 Beecham Group Plc Pyrano(3,2-c)pyridinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
GB8521857D0 (en) * 1985-09-03 1985-10-09 Beecham Group Plc Active compounds
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
GB8613786D0 (en) * 1986-06-06 1986-07-09 Beecham Group Plc Active compounds
GB8625185D0 (en) * 1986-10-21 1986-11-26 Beecham Group Plc Active compounds
ES2055709T3 (es) * 1986-12-06 1994-09-01 Beecham Group Plc Un procedimiento para preparar una composicion farmaceutica.
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
DE3881714D1 (de) * 1987-02-04 1993-07-22 Hoechst Ag Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
DK2689A (da) 1989-07-07
AU614008B2 (en) 1991-08-15
NZ227518A (en) 1991-08-27
EP0323745A2 (en) 1989-07-12
PT89388A (pt) 1990-02-08
US5032591A (en) 1991-07-16
DE3876773D1 (de) 1993-01-28
JPH01224316A (ja) 1989-09-07
AU2769689A (en) 1989-07-06
DE3876773T2 (de) 1993-04-29
ES2042776T3 (es) 1993-12-16
CA1317228C (en) 1993-05-04
GB8800199D0 (en) 1988-02-10
KR890011591A (ko) 1989-08-21
GR3006857T3 (ja) 1993-06-30
DK2689D0 (da) 1989-01-04
ATE83375T1 (de) 1993-01-15
EP0323745A3 (en) 1990-03-21
PT89388B (pt) 1993-09-30
EP0323745B1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
ZA8944B (en) K+ channel activator/beta-blocker compositions
IL91706A (en) Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin
AU3790689A (en) Derivatives of (aza) naphthalenesultam, their preparation and compositions containing them
AU5339594A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
IL92672A0 (en) Retroviral protease inhibitors,their preparation and pharmaceutical compositions containing them
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
EP0679717A3 (en) Soluble interferon receptor, its production and use.
AU4618989A (en) 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them
GR3003599T3 (ja)
PH24239A (en) New 4-pyridone derivatives,their pharmaceutical compositions and use
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL86909A0 (en) Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives
AU580890B2 (en) P-acylaminobenzamides
IL92107A0 (en) Quinazoline derivatives,and pharmaceutical compositions containing them
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
IL90958A0 (en) Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
AU642961B2 (en) Pharmaceutical composition
AU7696087A (en) Recombinant human tissue plasminogen activator composition
PH22684A (en) Antihypertensive agents, pharmaceutical compositions containing them and method of use thereof
AU609337B2 (en) Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof
ZA895199B (en) Derivatives of(aza)naphthalenesultam,their preparation and compositions containing them